KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Retained Earnings (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Retained Earnings for 16 consecutive years, with -$339.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 1415500.0% to -$339.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$339.7 million, a 1415500.0% decrease, with the full-year FY2025 number at -$339.7 million, down 1415500.0% from a year prior.
  • Retained Earnings was -$339.7 million for Q4 2025 at Biolife Solutions, up from -$350.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $33000.0 in Q1 2025 to a low of -$351.4 million in Q2 2025.
  • A 5-year average of -$127.5 million and a median of -$94.6 million in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: skyrocketed 106.96% in 2024, then tumbled 1415500.0% in 2025.
  • Biolife Solutions' Retained Earnings stood at -$107.1 million in 2021, then skyrocketed by 99.37% to -$679000.0 in 2022, then surged by 49.19% to -$345000.0 in 2023, then surged by 106.96% to $24000.0 in 2024, then crashed by 1415500.0% to -$339.7 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Retained Earnings are -$339.7 million (Q4 2025), -$350.8 million (Q3 2025), and -$351.4 million (Q2 2025).